Baicalein

DB16101InvestigationalSmall molecule

Baicalein is under investigation in clinical trial NCT03830684 (A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase ⅡA Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of...

Formula / weight: C₁₅H₁₀O₅ · 270.24 g/mol (avg)
Also known as: Noroxylin
Code names: NSC-661431

Resolves to

Compound

UNII49QAH60606CAS491-67-8ChEMBLCHEMBL8260ChEBI2979KEGGC10023

Clinical / RWD

RxNorm1592893

Structure

InChIKeyFXNFHKRTJBSTCS-UHFFFAOYSA-NSMILESOC1=CC2=C(C(O)=C1O)C(=O)C=C(O2)C1=CC=CC=C1

Targets

P09917ALOX5P16109SELPP48147PREPP14151SELLP47989XDHP01375TNFQ04760GLO1

What you can answer from here — as of January 29, 2025

7Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

16+ReferencesStructured and connected to the statements they support

Which drugs share a target with Baicalein, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account